[Funding alert] Engrail Therapeutics Secures $157 Mn Funding From F-Prime Capital, OthersInsightBy Viestories20 Mar 2024 10:01 ISTEngrail Therapeutics, a precision neuroscience company focused on the development of transformational therapies to improve the lives of patients, announced the close of an oversubscribed $157 million Series B financing round.Read More
![[Funding alert] Engrail Therapeutics Secures $157 Mn Funding From F-Prime Capital, Others](https://img-cdn.publive.online/fit-in/580x348/filters:format(webp)/viestories/media/post_attachments/wp-content/uploads/2024/03/Engrali.webp)